Evolent Health, Inc. EVH
4.30 USD -0.15 (-3.37%)
At closeNov 3, 2026, 5:55 PM EST
4.36 +0.06 +1.40%
After hours · Nov 3, 5:55 PM ET
4.27 Day range 4.44
2.10 52-week range 6.89
- YTD
- +7.50%
- 1 year
- -36.01%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.46 +259.6% upside
Now 4.30
- Target (low)
- 9.00
- Target (mean)
- 15.46
- Target (high)
- 20.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
- Strong buy4
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.10522 | 0.05456 – 0.20 | 0.04 | +163.1% | 473.74M | -23.8% | 11 |
| Next quarter | 0.12388 | 0.05 – 0.22 | -0.02 | +719.4% | 482.03M | -25.4% | 11 |
| Current year | 0.2243 | 0.03059 – 0.38 | 0.41 | -45.3% | 1.88B | -26.3% | 11 |
| Next year | 0.63439 | 0.41 – 1.12 | 0.2243 | +182.8% | 2.42B | +28.4% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 9, 2025 | BTIG | Reiterated | Buy | Buy |
| Aug 28, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 17, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jun 20, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 13, 2025 | Needham | Reiterated | Buy | Buy |
| May 9, 2025 | UBS | Maintained | Buy | Buy |
| Apr 28, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 10, 2025 | Truist Securities | Maintained | Buy | Buy |
| Mar 10, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 24, 2025 | Citizens Capital Markets | Maintained | Market Outperform | Market Outperform |
| Feb 21, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 21, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 14, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Feb 12, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 28, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 24, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Jan 24, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jan 23, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 22, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jan 21, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Jan 16, 2025 | UBS | Maintained | Buy | Buy |
| Jan 15, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 14, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 13, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jan 10, 2025 | Citigroup | Maintained | Buy | Buy |
| Jan 10, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jan 10, 2025 | Needham | Initiated | — | Buy |
| Nov 22, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 18, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
